Bureaucrats, checkuser, developer, editor, reviewer, Administrators, widgeteditor
1,951
edits
Changes
no edit summary
{{Drug
| name = Olanzapine
| group = Atypical atypical AP| type = antipsychotic| otheruse = moodstabilizer
| pubchem = 4585
| medscape = 1644
| emea = zyprexa
| ATC = N05AH03
| CAS = 132539-06-1
| ChemSpiderID = 10442212
| drugbank = APRD00138
| drugscom = olanzapine
| ftk = olanzapine
| metabolization = * Olanzapine is principally metabolized by CYP1A2 and CYP2D6.
| start =
| stop =
| equivalent = 0.4
| equivalent_ref = <ref>Woods SW Chlorpromazine equivalent doses for the newer atypical antipsychotics; ''J Clin Psychiatry'' 2003;'''64''':663-667</ref>
| comparison = haloperidol
<!--
| avail = unknown
-->
| halflife = 32-52
| halflife_ref = <ref name="informatorium">{{KNMP|olanzapine}}</ref>
| ct = 11
| ct_ref = <ref name="informatorium" />
| administration = oral
| dose = 2.5-20
| dose_ref = <ref name="informatorium" />
| DDD = 30
| DDD_ref = <ref name="informatorium" />
| ctox = 100
| ctox_ref = {{FTK-TOX}}
| <includeonly>| isswitch = 1 </includeonly>
}}
